UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

A Phase 3 Trial of Bevacizumab in Ovarian Cancer

The New England journal of medicine, 2011-12, Vol.365 (26), p.2484-2496

2011

Volltextzugriff (PDF)

Characteristics and outcome of recurrence in molecularly defined adult-type ovarian granulosa cell tumors

Gynecologic oncology, 2016-12, Vol.143 (3), p.571-577

2016

Volltextzugriff (PDF)

Exome sequencing identifies FANCM as a susceptibility gene for triple-negative breast cancer

Proceedings of the National Academy of Sciences - PNAS, 2014-10, Vol.111 (42), p.15172-15177

2014

Volltextzugriff (PDF)

MicroRNA Microarray Identifies Let-7i as a Novel Biomarker and Therapeutic Target in Human Epithelial Ovarian Cancer

Cancer research (Chicago, Ill.), 2008-12, Vol.68 (24), p.10307-10314

2008

Volltextzugriff (PDF)

Genomic and epigenetic alterations deregulate microRNA expression in human epithelial ovarian cancer

Proceedings of the National Academy of Sciences - PNAS, 2008-05, Vol.105 (19), p.7004-7009

2008

Volltextzugriff (PDF)

Aurora-A overexpression and aneuploidy predict poor outcome in serous ovarian carcinoma

Gynecologic oncology, 2011-01, Vol.120 (1), p.11-17

2011

Volltextzugriff (PDF)

Surveillance for endometrial cancer in hereditary nonpolyposis colorectal cancer syndrome

International journal of cancer, 2007-02, Vol.120 (4), p.821-824

2007

Volltextzugriff (PDF)

Clinical outcome and prognostic factors in 100 cases of uterine sarcoma: Experience in Helsinki University Central Hospital 1990–2001

Gynecologic oncology, 2008-10, Vol.111 (1), p.74-81

2008

Volltextzugriff (PDF)

A Combined Array-Based Comparative Genomic Hybridization and Functional Library Screening Approach Identifies mir-30d As an Oncomir in Cancer

Cancer research (Chicago, Ill.), 2012-01, Vol.72 (1), p.154-164

2012

Volltextzugriff (PDF)

Amitriptyline in the Prevention of Chemotherapy-induced Neuropathic Symptoms

Anticancer research, 2009-07, Vol.29 (7), p.2601-2606

2009

Volltextzugriff (PDF)

Updating on primary fallopian tube carcinoma

Acta obstetricia et gynecologica Scandinavica, 2007-01, Vol.86 (12), p.1419-1426

2007

Volltextzugriff (PDF)

Gene amplification, mutation, and protein expression of EGFR and mutations of ERBB2 in serous ovarian carcinoma

Journal of molecular medicine (Berlin, Germany), 2006-08, Vol.84 (8), p.671-681

2006

Volltextzugriff (PDF)

Vascular endothelial growth factor (VEGF) and its receptor VEGFR-2 are highly expressed in ovarian granulosa cell tumors

European journal of endocrinology, 2011-01, Vol.164 (1), p.115-122

2011

Volltextzugriff (PDF)

FIGO 1988 versus 2009 staging for endometrial carcinoma: a comparative study on prediction of survival and stage distribution according to histologic subtype

Journal of Gynecologic Oncology, 2014, 25(1), , pp.30-35

2014

Volltextzugriff (PDF)

GATA-4 Regulates Bcl-2 Expression in Ovarian Granulosa Cell Tumors

Endocrinology (Philadelphia), 2008-11, Vol.149 (11), p.5635-5642

2008

Volltextzugriff (PDF)

Sociodemographic determinants of incidence of primary fallopian tube carcinoma, Finland 1953–97

International journal of cancer, 2003-05, Vol.104 (5), p.643-645

2003

Volltextzugriff (PDF)

Magnetic Resonance Imaging in the Assessment of High-Risk Features of Endometrial Carcinoma: A Meta-Analysis

International journal of gynecological cancer, 2015-06, Vol.25 (5), p.837-842

2015

Volltextzugriff (PDF)

Ezrin immunoreactivity in relation to survival in serous ovarian carcinoma patients

Gynecologic oncology, 2003-08, Vol.90 (2), p.273-281

2003

Volltextzugriff (PDF)

The effect of hospital operative volume, residual tumor and first-line chemotherapy on survival of ovarian cancer — A prospective nation-wide study in Finland

Gynecologic oncology, 2009-11, Vol.115 (2), p.199-203

2009

Volltextzugriff (PDF)

Spread of Ovarian Cancer after Laparoscopic Surgery: Report of Eight Cases

Gynecologic oncology, 1999-12, Vol.75 (3), p.387-390

1999

Volltextzugriff (PDF)

Elevated Cyclooxygenase-2 Expression Is Associated with Altered Expression of p53 and SMAD4, Amplification of HER-2/neu, and Poor Outcome in Serous Ovarian Carcinoma

Clinical cancer research, 2004-01, Vol.10 (2), p.538-545

2004

Volltextzugriff (PDF)

Prediction of lymph node and distant metastasis in patients with endometrial carcinoma: A new model based on demographics, biochemical factors, and tumor histology

Gynecologic oncology, 2013-04, Vol.129 (1), p.28-32

2013

Volltextzugriff (PDF)

Prediction of lymphatic dissemination in endometrioid endometrial cancer: Comparison of three risk-stratification models in a single-institution cohort

Gynecologic oncology, 2017-03, Vol.144 (3), p.510-514

2017

Volltextzugriff (PDF)

The clinical utility of serum anti‐Müllerian hormone in the follow‐up of ovarian adult‐type granulosa cell tumors—A comparative study with inhibin B

International journal of cancer, 2015-10, Vol.137 (7), p.1661-1671

2015

Volltextzugriff (PDF)

Determinants of incidence of primary fallopian tube carcinoma (PFTC)

Methods in molecular biology (Clifton, N.J.), 2009, Vol.472, p.387

2009

Volltextzugriff (PDF)

1 – 25 von 110

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(104)
Mit Volltextzugriff
(95)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

A Phase 3 Trial of Bevacizumab in Ovarian Cancer

Characteristics and outcome of recurrence in molecularly defined adult-type ovarian granulosa cell tumors

Exome sequencing identifies FANCM as a susceptibility gene for triple-negative breast cancer

MicroRNA Microarray Identifies Let-7i as a Novel Biomarker and Therapeutic Target in Human Epithelial Ovarian Cancer

Genomic and epigenetic alterations deregulate microRNA expression in human epithelial ovarian cancer

Aurora-A overexpression and aneuploidy predict poor outcome in serous ovarian carcinoma

Surveillance for endometrial cancer in hereditary nonpolyposis colorectal cancer syndrome

Clinical outcome and prognostic factors in 100 cases of uterine sarcoma: Experience in Helsinki University Central Hospital 1990–2001

A Combined Array-Based Comparative Genomic Hybridization and Functional Library Screening Approach Identifies mir-30d As an Oncomir in Cancer

Amitriptyline in the Prevention of Chemotherapy-induced Neuropathic Symptoms

Updating on primary fallopian tube carcinoma

Gene amplification, mutation, and protein expression of EGFR and mutations of ERBB2 in serous ovarian carcinoma

Vascular endothelial growth factor (VEGF) and its receptor VEGFR-2 are highly expressed in ovarian granulosa cell tumors

FIGO 1988 versus 2009 staging for endometrial carcinoma: a comparative study on prediction of survival and stage distribution according to histologic subtype

GATA-4 Regulates Bcl-2 Expression in Ovarian Granulosa Cell Tumors

Sociodemographic determinants of incidence of primary fallopian tube carcinoma, Finland 1953–97

Magnetic Resonance Imaging in the Assessment of High-Risk Features of Endometrial Carcinoma: A Meta-Analysis

Ezrin immunoreactivity in relation to survival in serous ovarian carcinoma patients

The effect of hospital operative volume, residual tumor and first-line chemotherapy on survival of ovarian cancer — A prospective nation-wide study in Finland

Spread of Ovarian Cancer after Laparoscopic Surgery: Report of Eight Cases

Elevated Cyclooxygenase-2 Expression Is Associated with Altered Expression of p53 and SMAD4, Amplification of HER-2/neu, and Poor Outcome in Serous Ovarian Carcinoma

Prediction of lymph node and distant metastasis in patients with endometrial carcinoma: A new model based on demographics, biochemical factors, and tumor histology

Prediction of lymphatic dissemination in endometrioid endometrial cancer: Comparison of three risk-stratification models in a single-institution cohort

The clinical utility of serum anti‐Müllerian hormone in the follow‐up of ovarian adult‐type granulosa cell tumors—A comparative study with inhibin B

Determinants of incidence of primary fallopian tube carcinoma (PFTC)

Suchergebnisse filtern